Assertion: lopinavir ritonavir | /r/CapableOf | benefit clinical outcomes
Facets:
value: for patients
type: TRANSITIVE-OBJECT
Source sentences:
text: We found that neither lopinavir/ritonavir nor Arbidol could benefit clinical outcomes for patients and that they might bring some side effects," says co-senior author Linghua Li, Vice Director of the Centre for Infectious Diseases of Guangzhou Eighth People's Hospital in Guangzhou, China.